Evidence map›Paper›PMID 35317282›Full record

ArticleMolecular therapy. Nucleic acids2022

A tRNA-derived fragment from Chinese yew suppresses ovarian cancer growth via targeting

Kai-Yue Cao, Tong-Meng Yan, Ji-Zhou Zhang, Ting-Fung Chan, Jie Li, Chong Li, Elaine Lai-Han Leung, Jin Gao, Bao-Xian Zhang, Zhi-Hong Jiang

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Targeting NUCKS1 with a fragment of tRNANon-coding RNA research · 2025
    Article
  6. TRMT10A regulates tRNA-ArgCCT mCell death & disease · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Kai-Yue CaoState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR, China.
Tong-Meng YanState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR, China.
Ji-Zhou ZhangState Key Laboratory of Agrobiotechnology, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Ting-Fung ChanState Key Laboratory of Agrobiotechnology, School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Jie LiMedical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, P. R. China.
Chong LiMedical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, P. R. China.
Elaine Lai-Han LeungState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR, China.
Jin GaoIncreasepharm (Hengqin) Institute Co., Ltd, Zhuhai 519031, China.
Bao-Xian ZhangIncreasepharm (HK) Limited, Hong Kong SAR, China.
Zhi-Hong JiangState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR, China.
Macau University of Science and Technology · MOChinese University of Hong Kong · HKSouthwest University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug discovery from plants usually focuses on small molecules rather than such biological macromolecules as RNAs. Although plant transfer RNA (tRNA)-derived fragment (tRF) has been associated with the developmental and defense mechanisms in plants, its regulatory role in mammals remains unclear. By employing a novel reverse small interfering RNA (siRNA) screening strategy, we show that a tRF mimic (antisense derived from the 5' end of tRNA

Indexed as

ovarian cancerTaxus chinensistRFtRNATRPA1

Identifiers

PMID35317282
PMCPMC8905250
OpenAlexW4205443379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.